MSCI Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Unvested Weighted Average Grant Date Fair Value increased by 19.8% to $532.62 in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 19.8%, from $444.51 to $532.62. Over 5 years (FY 2020 to FY 2025), Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Unvested Weighted Average Grant Date Fair Value shows an upward trend with a 26.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in this value suggests that the company is granting more valuable equity, which may lead to higher future compensation expenses.
This represents the weighted average fair value at the time of grant for all outstanding equity instruments other than o...
Used by analysts to model non-cash compensation expenses; peers with higher grant-date fair values may be more sensitive to stock price volatility.
other_share_based_compensation_arrangement_by_share_base_3f8806| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $217.05 | $283.66 | $346.44 | $444.51 | $532.62 |
| QoQ Change | — | +30.7% | +22.1% | +28.3% | +19.8% |
| YoY Change | — | +30.7% | +22.1% | +28.3% | +19.8% |